Green Thumb Industries (GTBIF) Shares Outstanding (Weighted Average) (2018 - 2026)

Green Thumb Industries (GTBIF) reported Shares Outstanding (Weighted Average) of $230.6 million for Q1 2026, down 2.34% on a YoY basis from $236.1 million in Q1 2025, and down 1.4% quarter-over-quarter from $233.9 million in Q4 2025.

Green Thumb Industries (GTBIF) Shares Outstanding (Weighted Average) (2018 - 2026) Analysis & Trends

Green Thumb Industries has reported Shares Outstanding (Weighted Average) for 9 years, with the latest figure at $230.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) fell 2.34% year-over-year to $230.6 million; the trailing twelve-month figure through Mar 2026 stood at $230.6 million (down 2.34% YoY), and the FY2025 full-year result was $233.9 million, down 1.26% from the prior year.
  • Shares Outstanding (Weighted Average) for Q1 2026 stood at $230.6 million, down from $233.9 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $239.5 million in Q3 2023, with the low at $230.6 million in Q1 2026.
  • Historically, Shares Outstanding (Weighted Average) has averaged $236.1 million across 5 years, with a median of $236.8 million in 2024.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) increased 9.08% — and 2026, when it decreased 2.34%.
  • Green Thumb Industries' Shares Outstanding (Weighted Average) stood at $236.7 million in 2022, then rose by 0.51% to $237.9 million in 2023, then decreased by 0.45% to $236.8 million in 2024, then fell by 1.26% to $233.9 million in 2025, then slipped by 1.4% to $230.6 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $230.6 million (Q1 2026), $233.9 million (Q4 2025), and $231.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 5.02 Bn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 100.50 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 64.74 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Green Thumb Industries - - 143.65 Mn 230.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 230.60 Mn
Dec 31, 2025 233.87 Mn
Sep 30, 2025 231.65 Mn
Jun 30, 2025 235.84 Mn
Mar 31, 2025 236.12 Mn
Dec 31, 2024 236.85 Mn
Sep 30, 2024 236.30 Mn
Jun 30, 2024 237.42 Mn
Mar 31, 2024 236.76 Mn
Dec 31, 2023 237.93 Mn
Sep 30, 2023 239.46 Mn
Jun 30, 2023 238.00 Mn
Mar 31, 2023 237.40 Mn
Dec 31, 2022 236.71 Mn
Sep 30, 2022 237.00 Mn
Jun 30, 2022 236.78 Mn
Mar 31, 2022 235.84 Mn
Dec 31, 2021 223.19 Mn
Sep 30, 2021 226.53 Mn
Jun 30, 2021 220.32 Mn